Skip to main content
Clinical Trials/NCT01336790
NCT01336790
Recruiting
Not Applicable

The International Lymphatic Disease and Lymphedema Patient Registry and Biorepository

Stanford University1 site in 1 country5,000 target enrollmentMarch 2009
ConditionsLymphedema

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lymphedema
Sponsor
Stanford University
Enrollment
5000
Locations
1
Primary Endpoint
prevalence of lymphatic disease
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of the International Lymphatic Disease and Lymphedema Patient Registry and Biorepository is to collect health information in order to study the disease classification, natural history, and impact of Lymphatic Disease, Lymphedema and Related Disorders and its treatments and medical outcomes.

Detailed Description

This project represents the inauguration of an International Patient Registry for Lymphatic Diseases. This project will be completed through an affiliation with the Lymphatic Education \& Research Network, a non-profit organization whose mission is to promote research and the development of new therapies for patients with lymphatic diseases, including lymphedema. The registry will provide researchers with much-needed clinical data to study the impact of diseases of the lymphatic system, in order to develop improved treatments and find a cure for lymphatic diseases, lymphedema, and related disorders. The establishment of this initiative is a major step forward in research for direct study of groups of patients with lymphatic disease. In the future, this project will be able to be linked with a biorepository, in which tissue and blood samples derived from patients will be made available for research into human disease states. An international patient registry and tissue/cell bank program paves the way for future clinical trials of experimental drugs and therapies designed to treat lymphatic disease in human subjects.

Registry
clinicaltrials.gov
Start Date
March 2009
End Date
December 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Stanley Rockson

Allan and Tina Neill Professor of Lymphatic Research and Medicine

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Presence of lymphatic disease

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

prevalence of lymphatic disease

Time Frame: 15 years

Secondary Outcomes

  • socioeconomic impact of lymphatic disease(15 years)

Study Sites (1)

Loading locations...

Similar Trials